This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Katie Landes
Executive Director, Head of Patient Advocacy and Government Affairs at Stealth Biotherapeutics
Speaker

Profile

Katie Landes is the Executive Director, Head of Patient Advocacy and Government Affairs at Stealth BioTherapeutics. In this role, Katie leads Stealth’s engagement with multiple patient advocacy groups as well as developing and implementing a comprehensive government relations strategy. She aims to serve as the "voice of the patient" within Stealth to ensure that the patient/caregiver perspective is adequately and appropriately represented across all aspects of the company’s operations. Prior to joining Stealth, Katie worked at a concierge government and public affairs firm based out of Washington DC with a focus on developing and implementing public and government affairs strategies for rare disease biotech companies.

Agenda Sessions

  • Maximizing Patient Advocacy Partnerships – Creating Strategic Value Through Collaborative Engagement

    8:15am